Consumer insights from a feasibility study on remote and extended use of a novel non-invasive wearable fetal electrocardiogram monitor
- PMID: 40259059
- PMCID: PMC12012179
- DOI: 10.1038/s41746-025-01628-9
Consumer insights from a feasibility study on remote and extended use of a novel non-invasive wearable fetal electrocardiogram monitor
Abstract
The COVID-19 pandemic accelerated the adoption of telehealth and remote monitoring in obstetric care. This study assessed pregnant patients' perceptions before and after using a novel non-invasive fetal electrocardiogram (NI-FECG) device. The trial is prospectively registered on the Australia New Zealand Clinical Trials Registry (ANZCTRN12621001260819; submitted June 9th, 2021; approved September 17th, 2021). Seventy participants from 36 weeks' gestation completed pre- and post-use surveys. Interest in continuous and home fetal monitoring was high (79% and 90%, respectively). Post-use, 89% reported satisfaction; over 90% comfortable wearing and removing the sensor. Extended use was acceptable to 76%, and only 3% reported high skin irritation. Sentiment analysis highlighted themes of reassurance, convenience, and reduced anxiety. Some suggested smaller, wireless design. Analysis by natural language processing and clustering provided deeper insights. Findings support strong interest in at-home fetal monitoring; further refinement and education are needed to enhance acceptability. Future research should assess long-term effects on anxiety and clinical outcomes.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: F.B. and E.K. are directors and shareholders of Kali Healthcare, a company that is commercializing a wearable fetal monitoring device. M.P. is a shareholder of Kali Healthcare. The remaining authors declare no competing interests.
Figures



Similar articles
-
Women's experience of wearing a portable fetal-electrocardiogram device to monitor small-for-gestational age fetus in their home environment.Womens Health (Lond). 2018 Jan-Dec;14:1745506518785620. doi: 10.1177/1745506518785620. Womens Health (Lond). 2018. PMID: 29968515 Free PMC article.
-
Novel uterine contraction monitoring to enable remote, self-administered nonstress testing.Am J Obstet Gynecol. 2022 Apr;226(4):554.e1-554.e12. doi: 10.1016/j.ajog.2021.11.018. Epub 2021 Nov 8. Am J Obstet Gynecol. 2022. PMID: 34762863 Clinical Trial.
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Pregnancy in the time of COVID-19: towards Fetal monitoring 4.0.BMC Pregnancy Childbirth. 2023 Jan 16;23(1):33. doi: 10.1186/s12884-023-05349-3. BMC Pregnancy Childbirth. 2023. PMID: 36647041 Free PMC article. Review.
-
Feasibility of a RCT of techniques for managing an impacted fetal head during emergency caesarean section: the MIDAS scoping study.Health Technol Assess. 2023 Mar;27(6):1-87. doi: 10.3310/KUYP6832. Health Technol Assess. 2023. PMID: 37022927 Free PMC article.
References
-
- Bekker, M. N. et al. Home telemonitoring versus hospital care in complicated pregnancies in the Netherlands: a randomised, controlled non-inferiority trial (HoTeL). Lancet Digit. Health5, e116–e124 (2023). - PubMed
-
- Hamm, R.F. et al. Use of a wireless monitoring device to perform nonstress tests from home: the patient perspective. Am. J. Obstetr. Gynecol. 6 (2014). - PubMed
LinkOut - more resources
Full Text Sources